Subsequently, through cloning, we found that under the treatment of TMZ, the proliferation ability of glioma cells significantly weakened after p62 knockdown and even reversed the phenomenon of ADAR1 overexpression (Figure 5A,B). This evidence concerns the gene SQSTM1 and central nervous system cancer.